Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Galectin 3 ELISA Kit (AC3740)
Cat.#: ASET-2329
Specifications
Description Mouse Galectin 3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Galectin 3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.02 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2356 Rat DDAH2 ELISA Kit (AC3767) Quantitative inquiry ASET-1867 Human Visfatin ELISA Kit (AC3278) Quantitative inquiry ASET-1314 Human 5HT3B Receptor ELISA Kit (AC2725) Quantitative inquiry ASET-1118 Mouse Ephrin A4 ELISA Kit (AC2529) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1408 Horse Luteinizing Hormone ELISA Kit (AC2819) Quantitative inquiry ASET-2362 Mouse GJB2 ELISA Kit (AC3773) Quantitative inquiry ASET-2074 Porcine Luteinizing Hormone ELISA Kit (AC3485) Quantitative inquiry ASET-1952 Human Somatostatin ELISA Kit (AC3363) Quantitative inquiry ASET-2143 Human Ephrin A3 ELISA Kit (AC3554) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket